Getinge (OTCMKTS:GNGBY – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.47 earnings per share for the quarter, Zacks reports. Getinge had a return on equity of 10.64% and a net margin of 5.77%.
Getinge Stock Performance
Shares of GNGBY traded up $0.06 during mid-day trading on Tuesday, reaching $23.62. The company’s stock had a trading volume of 6,838 shares, compared to its average volume of 2,102. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.80 and a current ratio of 1.34. Getinge has a 1-year low of $17.70 and a 1-year high of $24.67. The business has a 50-day simple moving average of $23.02 and a two-hundred day simple moving average of $22.23.
Analyst Ratings Changes
Separately, Nordea Equity Research raised shares of Getinge from a “hold” rating to a “buy” rating in a research note on Wednesday, October 22nd. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Getinge has a consensus rating of “Moderate Buy”.
About Getinge
Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.
The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.
Featured Articles
- Five stocks we like better than Getinge
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The $100 Trillion AI Story No One Is Telling You
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
